Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' DEFICIT (Details Narrative)

STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($)				3 Months Ended	6 Months Ended
STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($)	Jan. 15, 2016	Aug. 20, 2015	Jan. 08, 2015	Mar. 31, 2016	Mar. 31, 2016	Sep. 30, 2015	Mar. 26, 2013	Dec. 10, 2012	Mar. 22, 2012	Aug. 03, 2006
Common stock authorized				500,000,000	500,000,000	500,000,000
Common and preferred stock authorized				515,000,000	515,000,000
Blank-check preferred stock authorized				15,000,000	15,000,000
Blank-check preferred stock par value (in dollars per share)				$ 0.001	$ 0.001
Common stock issued				102,717,409	102,717,409	102,417,409
Common stock outstanding				102,717,409	102,717,409	102,417,409
Number of options outstanding				14,230,011	14,230,011	14,230,011
Number of options exercised
Common stock exercise price (in dollars per share)				$ 0.75	$ 0.75	$ 0.75
Number of stock options granted
Total unrecognized stock-based compensation				$ 145,443	$ 145,443
Consulting Agreement [Member] \| Dian Griesel International [Member]
Monthly professional fees	$ 5,000
Consulting Agreement [Member] \| Dian Griesel International [Member]
Aggregate intrinsic value of awarded shares	$ 6,900
Number of shares issued upon services	300,000
Warrant [Member]
Number of equity instruments other than options outstanding				87,946,522	87,946,522
Description of warrant term				The warrants expire at various times starting 2016 through 2020.
Minimum [Member] \| Warrant [Member]
Common stock exercise price (in dollars per share)				$ 0.04718	$ 0.04718
Maximum [Member] \| Warrant [Member]
Common stock exercise price (in dollars per share)				$ 9.00	$ 9.00
2006 Stock Incentive Plan [Member]
Number of shares reserved for future issuance										667,667
Number of options outstanding				501,924	501,924
Number of options exercised					70,825
2006 Stock Incentive Plan [Member] \| Minimum [Member]
Common stock exercise price (in dollars per share)										$ 3.6
2006 Stock Incentive Plan [Member] \| Maximum [Member]
Common stock exercise price (in dollars per share)										$ 32.7
2012 Omnibus Incentive Compensation Plan [Member]
Number of shares reserved for future issuance				521,913	521,913
Number of options outstanding				13,728,087	13,728,087
Common stock exercise price (in dollars per share)			$ 0.25
Number of options authorized							15,000,000	5,500,000	333,334
Number of stock options granted			250,000
Description of vesting rights			The option vesting is contingent upon the achievement of agreed upon goals.
Restricted Stock [Member] \| 2006 Stock Incentive Plan [Member]
Number of equity instruments other than options outstanding				6,132	6,132
Restricted Stock [Member] \| 2012 Omnibus Incentive Compensation Plan [Member]
Number of equity instruments other than options outstanding				750,000	750,000
Option [Member]
Number of shares				14,230,011	14,230,011
Option [Member] \| $0.055 [Member]
Common stock exercise price (in dollars per share)				$ 0.055	$ 0.055
Number of shares				1,750,000	1,750,000
Robin L. Smith [Member] \| Restricted Stock [Member]
Weighted exercise price of awarded shares (in dollars per share)		$ 0.055
Number of awarded shares		750,000
Aggregate intrinsic value of awarded shares		$ 41,250
Issuance date		Oct. 30, 2015
Management [Member] \| Option [Member] \| $0.055 [Member]
Common stock exercise price (in dollars per share)		$ 0.055
Number of shares		1,750,000
Expiration period		36 months